52 Week Range
As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Smiths Group Says Qtrly Cont Ops Revenue Was Up 1% On An Underlying Basis
Japan Customs And Smiths Detection To Boost Surveillance With State-Of-The-Art Inspection System
Smiths Group FY Revenue Falls To 2,406 Mln Stg
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect and Smiths Medical. John Crane provides mission-critical solutions such as mechanical seals, seal support systems, power transmission couplings and filtration systems for global energy and process industries. Smiths Detection produces detection and screening technologies for the identification of safety and security threats. Flex-Tek provides engineered components that heat and move fluids and gases for aerospace, consumer products, construction, medical and industrial applications. Smiths Interconnect provides electronic components, subsystems, microwave and radio frequency products that provide secure connectivity of critical applications in the defense, aerospace, communications and industrial markets. Smiths Medical offers medical devices and consumables in the select segments of the infusion systems, vascular access and vital care markets.
Misc. Capital Goods
4th Fl, 11-12 St. James's Square
George W. Buckley
Non-Executive Independent Chairman of the Board
Paul A. Keel
Chief Executive Officer, Executive Director
John Francis Shipsey
Chief Financial Officer, Executive Director
President, Smiths Detection and Asia Pacific
President - Smiths Interconnect
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
London's FTSE 100 was subdued on Tuesday as losses in mining heavyweights outweighed strength in energy shares, while Smiths Group topped the blue-chip index after the technology company delivered positive full-year results.
British industrial technology group Smiths has agreed to sell its medical division to U.S.-based ICU Medical for $2.4 billion, it said on Wednesday, scrapping an earlier $2 billion deal with private equity firm TA Associates.
British engineering and technology company Smiths Group said on Monday it will sell its medical unit for $2.3 billion including debt to U.S. private equity firm TA Associates as it focuses on its core industrial technology business.
(The author is a Reuters Breakingviews columnist. The opinions expressed are their own.)
U.S. private equity firm TA Associates has made a 2 billion pounds ($2.78 billion) takeover approach for the medical division of Smiths Group Plc, which makes ventilators for hospitals, the Mail on Sunday reported https://bit.ly/3e9oIuF.
Britain's Smiths Group Plc said on Tuesday it has appointed Paul Keel as its new chief executive officer as the technology company braces for a next growth phase following a long-sought separation of its medical unit.
Britain's Smiths Group Plc said on Monday it has appointed Paul Keel as its new chief executive officer.
Smiths Group said on Friday it expects to meet market expectations for the fiscal year, as the British engineering firm forecast improving trends for the current half on the back of better-than-estimated interim profit.
Smiths Group on Friday forecast improving trends for the second half of the fiscal year after the British engineering firm reported a better-than-expected profit and added that it was on track to separate its medical unit by the fourth quarter.
Smiths Group reported a 26% fall in annual operating profit on Thursday due to higher costs and a hit from the COVID-19 pandemic, while the British engineering firm also said it was cutting jobs as part of its restructuring plan.
Smiths Group <SMIN.L> reported a lower annual profit on Thursday due to higher costs and a hit from the COVID-19 pandemic, while the British engineering firm also said it would cut jobs as part of its restructuring plan.
* SMITHS DETECTION ANNOUNCES PARTNERSHIP WITH ATTOMARKER IN THE DEVELOPMENT OF A TRIPLE ANTIBODY TESTING DEVICE FOR COVID-19
Smiths Group <SMIN.L> will help produce a blood-based COVID-19 antibody test approved by Britain's healthcare regulator in the firm's latest involvement in tackling the coronavirus.
Britain's Smiths Group on Wednesday said it would help produce a blood-based COVID-19 antibody test approved by the country's regulators, another move by the technology firm to develop products to combat the pandemic.
UK's Smiths Group <SMIN.L> said on Tuesday the separation of its medical unit will be delayed, as it focuses on making and delivering ventilators and critical-care devices to hospitals tackling the shortage of life-saving equipment as the coronavirus spreads.
UK's Smiths Group said on Tuesday the separation of its medical unit will be delayed, as it focuses on making and delivering ventilators to hospitals tackling the shortage of life-saving equipment as the coronavirus spreads.
* SMITHS GROUP - ANNOUNCES A DELAY TO SEPARATION OF SMITHS MEDICAL
* SMITHS GROUP PLC - FCA MORATORIUM ON PUBLICATION OF RESULTS
* PRESS RELEASE - SMITHS GROUP SIGNIFICANTLY RAMPING UP WEEKLY PRODUCTION OF VENTILATORS
Smiths Group Plc's Chief Executive Andy Reynolds Smith will likely step down next year after a demerger of its medical unit, the Sunday Times reported.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.